Coronavirus czar Salman Zarka says vaccines likely work against the Omicron strain, though he notes that the emergence of the viral mutant presents a “complicated situation.”
“There’s uncertainty; we need to decide what is correct to do with the uncertainty; I think the cabinet made the right choices,” he says, according to Ynet.
He adds that “there’s no room for panic. The vaccine gives us good protection, especially against severe cases, and so it’s important to get vaccinated.”
Others have expressed less certainty regarding the vaccine’s efficacy against the variant.
“At least from a speculative point of view we have some optimism that the vaccine should still work against a new variant for serious disease, but really we need to wait several weeks to have that confirmed,” Prof. Andrew Pollard, the director of the Oxford Vaccine Group, which developed the AstraZeneca vaccine, tells BBC radio.
A number of pharmaceutical firms, including AstraZeneca, Moderna, Novavax and Pfizer, say they have plans in place to adapt their vaccines in light of the emergence of Omicron. Pfizer and its partner BioNTech say they expect to be able to tweak their vaccine in around 100 days.
The Associated Press contributed to this report.
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this